Back to News
Market Impact: 0.35

Salesforce Plunges 20% in a Year: Is CRM Stock Still a Hold?

CRMSAPMSFTORCLITINFANVDA
Artificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate EarningsAnalyst EstimatesM&A & RestructuringProduct LaunchesInvestor Sentiment & Positioning
Salesforce Plunges 20% in a Year: Is CRM Stock Still a Hold?

Salesforce shares have lagged peers, down 17.9% over the past year versus a 10.7% gain for the Zacks Computer–Software industry (Microsoft +14.1%, Oracle +23%, SAP -4.2%). Growth is decelerating—revenues rose 8.7% year-over-year in the first nine months of fiscal 2026 and Zacks forecasts revenue growth of 9.5% and 11% for fiscal 2026 and 2027; EPS is projected to grow at a 15% CAGR over the next five years versus a 27.8% prior five-year CAGR, with FY26/FY27 EPS up 15.3% and 10.4%, respectively. Offsetting the slowdown, AI and platform initiatives are driving strong uptake: Data Cloud and AI offerings generated $1.4 billion in recurring revenues in Q3 FY26 (+114% YoY) and Agentforce contributed $540 million (+330% YoY) with over half of deals from existing customers. Valuation also supports a hold stance—forward 12-month P/E of 20.16 versus industry 28.47—and Zacks currently assigns a #3 (Hold) rank.

Analysis

Market structure: Salesforce (CRM) is trading as a discounted high-quality software franchise (forward P/E ~20 vs. peers 24–29) while AI-driven incumbents (MSFT, ORCL) are re-capturing investor preference. Winners in the near term are platform/infrastructure providers (MSFT, ORCL, INFA) capturing predictable cloud spend and margin; legacy point-solution vendors and smaller SaaS players face elongating sales cycles. Rising IT spend (Gartner +9.8% in 2026; software +15.2%) supports demand but shifts supply/demand toward integrated AI/data stacks rather than standalone CRM modules. Risk assessment: Tail risks include failed integration of acquisitions (Informatica/Slack), an AI adoption slowdown (Agentforce growth <100% YoY), or regulatory/antitrust scrutiny of large M&A; any could compress multiples by 20–35%. Time horizons matter: days–weeks driven by sentiment and options flows, months by quarterly adoption metrics (Agentforce/Data Cloud recurring revenue), and years by execution on cross-sell and margin expansion. Hidden dependencies: CRM’s recovery depends on cross-sell penetration (>50% current) converting into net-new ARR rather than churn masking renewal mix. Trade implications: Construct tactical, hedged exposure — accumulate CRM on measured dips and use pair trades to neutralize market beta. Use defined-risk options (calendar/bull-call spreads) around earnings and sell premium on elevated short-term IV to finance longer-dated upside exposure. Rotate 1–3% of equity book from expensive AI laggards into durable software cash-flow names (ORCL, MSFT) while keeping a small growth-biased CRM core. Contrarian angles: Consensus underestimates durability of cross-sell economics — Agentforce + Data Cloud at $1.4bn recurring revenue and 114% YoY suggests structural upsell runway; market may be over-penalizing single-digit topline growth temporarily. Reaction may be overdone if CRM stabilizes margins and posts sequential acceleration in AI ARR over two quarters; conversely, success could re-rate CRM toward peer multiples (20→24) implying ~20% upside absent broader market moves.